Skip to main content
logo
Nuvation Bio Inc. (NUVB)
NYSE: NUVB · Real-Time Price · USD
6.66
0.00 (0.00%)
Aug 31, 2026, 4:00 PM EDT - Market closed

Nuvation Bio Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
169.962.97.87---
Revenue Growth
1083.56%698.96%----
Gross Profit
149.8153.60.8---
Operating Income
-137.63-213.06-167.56-99.82-119.73-89.53
Net Income
-149.83-204.63-567.94-75.8-104.2-86.85
Earnings Per Share
-0.44-0.60-2.11-0.35-0.48-0.44
EPS Growth
------

Revenue by Geography
Chart
Fiscal YearTTMFY 2025FY 2024
Period EndingJun '26 Dec '25 Dec '24
United States
12424.66-
China
16.349.415.15
Japan
29.5628.832.73
Total
169.962.97.87

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
660.96529.21502.69611.21661.01765.39
Total Debt
416.2666.948.924.014.263.06
Net Cash (Debt)
244.69462.27493.78607.21656.75762.34
Net Cash Growth
-39.49%-6.38%-18.68%-7.54%-13.85%253.34%
Net Cash Per Share
0.721.351.842.773.033.85

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-120.52-173.43-130.41-68-96.11-68.19
Capital Expenditures
-0.4-0.35-0.16-0.07-0.37-0.28
Free Cash Flow
-120.93-173.78-130.58-68.07-96.48-68.47
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
88.17%85.22%10.10%---
Operating Margin
-81.00%-338.72%-2128.25%---
Pretax Margin
-88.19%-325.31%-7213.76%---
Profit Margin
-88.19%-325.31%-7213.76%---
FCF Margin
-71.17%-276.27%-1658.52%---

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
13.7648.83113.71---